Oral Tranexamic Acid for the Treatment of Melasma: Evidence and Experience-Based Consensus Statement from Indian Experts

Melasma, a chronic pigmentary skin condition mainly affecting the face, remains a challenge despite the availability of several options for treatment. Many melasma patients are not satisfied with treatment outcomes. Tranexamic acid (TXA), an anti-fibrinolytic drug has shown promising results in pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Godse, Kiran, Sarkar, Rashmi, Mysore, Venkataram, Shenoy, Manunath M., Chatterjee, Manas, Damisetty, Rajetha, Shah, Swapnil, Vedamurthy, Maya, Aurangabadkar, Sanjeev, Srinivas, Chakravarthi, Ganjoo, Anil, Das, Sudip, Patil, Anant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238972/
https://www.ncbi.nlm.nih.gov/pubmed/37275826
http://dx.doi.org/10.4103/ijd.ijd_266_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238972/
https://www.ncbi.nlm.nih.gov/pubmed/37275826
http://dx.doi.org/10.4103/ijd.ijd_266_22

Ejemplares similares